During the past decade, few biological disciplines have captivated researchers as dramatically as immunology. Of particular interest are the molecules known as antibodies -- naturally occurring immune system proteins that seek out and bind to a virtually unlimited number of antigens, peptides, receptors, infectious organisms, other proteins, and so on. Their remarkable specificity and selectivity have driven the growth in the use of antibodies as the basis of dozens of commercial diagnostic processes and products.
ACCURATE OFFERINGS: Accurate Chemical and Scientific's Axell polyclonal rabbit anti-CD44v3, left, for study of changes during tumor metastasis, and Axyll monoclonoal rat anti-MMSTR (metastasis marker for solid tumors) Like hundreds of other companies involved in biomedical research, Amersham International plc is finding its fortunes increasingly linked to antibody technology. Offering some 2,000 products pegged to major pharmaceutical companies, researchers, and other customers in the life ...
